1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Cenntro Inc. closed a private placement on September 15, 2026, after amending its August 25, 2026 purchase agreement on September 14 to raise the offering size. The company received gross proceeds of approximately $57,047,760 and says it will use the money for working capital and general corporate purposes. Shareholders face dilution from the sale of up to 15,120,000 new shares at $3.773 each.
Sale of up to 15,120,000 shares of common stock at $3.773 per share, up from an original offering of up to 12,800,000 shares
Gross proceeds of approximately $57,047,760; private placement closed September 15, 2026
Shares sold to non-U.S. accredited investors under Section 4(a)(2) and Regulation S, without general solicitation
Proceeds intended for working capital and general corporate purposes
In an Investor Day presentation furnished under Form 8-K, Salesforce reiterated its FY27 revenue guidance at the high end of $46.1 billion to $46.4 billion and set a FY30 revenue target of $63 billion-plus. The company also disclosed a $25 billion accelerated share repurchase, which it expects to reduce its share count by at least 14%, a step that matters to shareholders because it returns capital and lifts per-share metrics.
FY27 revenue guidance is the high end of $46.1 billion to $46.4 billion, as of August 2026.
FY27 non-GAAP operating margin guidance is 34.3%, compared with 34.1% in FY26.
The $25 billion accelerated share repurchase is described as the company's largest ever, with an expected average share price of $182.
The FY30 revenue target of $63 billion-plus was stated as of May 2026 and includes Informatica.
Mechanics Bank, a subsidiary of Mechanics Bancorp, completed the sale of approximately $417 million of its remaining performing indirect auto loans to Bank of America's trading desk, at a price near book value with an August 31, 2026 cutoff date. The bank retains about $13 million of runoff auto loans, and the company says the sale will reduce risk, improve liquidity and enhance future profitability. The filing does not quantify any gain, loss or earnings effect.
Sale of approximately $417 million of remaining performing indirect auto loans to Bank of America's trading desk
Loans sold at a price near book value, with an August 31, 2026 cutoff date
Mechanics Bank retains approximately $13 million of runoff auto loans; Westlake Portfolio Management will service loans for both parties
Filing gives no gain, loss or earnings figure from the sale
Beta Bionics priced an underwritten public offering of 7,652,175 common shares at $17.25 per share, plus pre-funded warrants for 1,043,484 shares, with gross proceeds expected to be about $150.0 million before underwriting discounts and expenses. The company expects to use the net proceeds for general corporate purposes, including costs of commercializing Mint and manufacturing expansion, and the offering is expected to close on September 17, 2026. The sale of new shares will increase the number of shares outstanding, which affects existing shareholders' ownership.
Offering of 7,652,175 common shares at $17.25 per share, plus pre-funded warrants for 1,043,484 shares at $17.2499 per share
Gross proceeds expected to be about $150.0 million before underwriting discounts and offering expenses
Underwriters have a 30-day option to buy up to 1,304,348 additional shares at the public offering price
Expected closing on September 17, 2026; J.P. Morgan, Piper Sandler, Wells Fargo Securities and Leerink Partners are the underwriters
Impact Biomedical said a Form F-4 registration statement for its proposed merger with Zoar Limited was filed with the SEC on September 10, 2026, and announced it on September 16, 2026. The filing is a step toward closing, which remains subject to SEC effectiveness, Impact stockholder approval, and NYSE American approval of the listing of PubCo shares.
Form F-4 registration statement filed with the SEC on Thursday, September 10, 2026, by Zoar Limited (PubCo)
Closing is subject to SEC effectiveness, Impact stockholder approval, and NYSE American listing approval
Combined company expected to be a pharmaceutical company focused on Active Pharmaceutical Ingredients and intermediates
Nordicus Partners issued a $600,000 convertible grid promissory note to Keystone Capital Partners on September 10, 2026, in exchange for $500,000 in cash. The company also agreed to issue the lender 250,000 shares of common stock as consideration for the funding commitment. Conversion into common stock is possible only after an Event of Default and from June 10, 2027, at 90% of VWAP, so existing shareholders could face dilution.
Principal of $600,000 for $500,000 in cash; interest at 5.0% per annum; matures June 10, 2027
Company agreed to issue 250,000 Commitment Shares to the lender
Conversion only after an Event of Default and from June 10, 2027, at 90% of the 10-day VWAP
Company must file a resale registration statement on or before November 1, 2026
On September 10, 2026, Aperture AC, a Cayman Islands SPAC, signed a Business Combination Agreement with Atlantic HPC Group Inc. Atlantic stockholders would receive SPAC common stock worth $150 million at $10.00 per share, plus up to 6,000,000 earnout shares tied to share price targets and a data center lease. The deal requires approval from both sets of shareholders, and Aperture public shareholders would be able to request redemption of their shares.
Agreement signed September 10, 2026, with Atlantic HPC Group Inc, a Delaware corporation; Aperture would re-domicile to Delaware and merge with a Merger Sub, with Atlantic as the surviving subsidiary
Merger consideration: SPAC common stock with an aggregate value of $150,000,000, valued at $10.00 per share
Earnout of up to 6,000,000 shares over five years after closing: 1,500,000 shares at a $12.50 VWAP, 1,500,000 more at $15.00, and 3,000,000 if a five-megawatt data center lease with a seven-year term is signed
Closing requires an Aperture extraordinary general meeting and Atlantic stockholder approval; a Form S-4 registration statement is to be filed with the SEC
Tenon Medical said holders exercised 572,179 existing warrants at $5.02 per share, bringing gross proceeds of $2,872,338.58, and received new five-year warrants for 858,269 shares at the same price. The deal was announced September 11, 2026 and closed September 14, 2026, with the company stating it will use the proceeds for working capital and general corporate purposes. Shareholders may face dilution if the new warrants are exercised, and the company agreed to register the resale of the underlying shares.
Existing warrants for 572,179 shares were exercised at $5.02 per share, with gross proceeds of $2,872,338.58, according to the filing.
New Series B warrants cover up to 858,269 shares, equal to 150% of the shares issued on exercise, with a $5.02 exercise price and a five-year term.
WallachBeth Capital LLC, the financial advisor, will receive a cash fee of 7% of gross proceeds plus legal expense reimbursement up to $65,000.
Tenon must file a resale registration statement within 30 calendar days of September 11, 2026 and seek effectiveness within 60 days, or 90 days if the SEC conducts a full review.
Battalion Oil Corporation received a letter from NYSE American saying it is back in compliance with the Exchange's continued listing standards. The Exchange had flagged a minimum stockholders' equity deficiency in May 2025, and the company has now met the requirement for two consecutive quarters, ahead of its November 30, 2026 compliance deadline. For shareholders, this removes the listing-standard noncompliance flag on the stock, though the filing does not describe the company's financial results.
NYSE American letter dated September 16, 2026 confirms compliance with Part 10 continued listing standards
Deficiency under Sections 1003(a)(i) and 1003(a)(ii), relating to minimum stockholders' equity, was first noticed on May 30, 2025
Compliance regained two consecutive quarters under Section 1009(f), ahead of the November 30, 2026 deadline
Company will be removed from the Exchange's list of noncompliant issuers and its compliance indicator will no longer be disseminated
On September 14, 2026, Essential Properties Realty Trust and its operating partnership signed an eighth amendment to their Amended and Restated Credit Agreement with Wells Fargo as administrative agent. The amendment raises revolving commitments from $1.0 billion to $1.3 billion, lowers margin pricing, and resets the accordion feature, and the company repaid and terminated its Capital One credit agreement in connection with it. The filing does not give a financial impact beyond these terms.
Revolving Credit Facility commitments increase from $1.0 billion to $1.3 billion, per the amendment dated September 14, 2026.
Margin grid pricing for the Revolving Credit Facility and term loans is reduced.
Accordion feature reset to permit $700.0 million of availability.
Obligations under the Capital One Credit Agreement were repaid in full and that agreement was terminated; Subsidiary Guarantors were released from their guarantee obligations.
Matinas BioPharma's board approved a one-for-fifteen reverse stock split of its common stock, which takes effect at 12:01 a.m. Eastern Time on September 28, 2026, with shares trading on a split-adjusted basis under the symbol MTNB. The filing says each stockholder's ownership percentage and voting power will remain essentially unchanged, and the company states there is no assurance the split will keep its shares listed on the NYSE American.
Reverse split ratio: one-for-fifteen (1:15), approved under authority granted by stockholders on June 23, 2025
Effective date: 12:01 a.m. Eastern Time on September 28, 2026; new CUSIP number 576810 402
Fractional shares will be replaced by a proportional cash payment; holders in brokerage accounts need not act
The company states there can be no assurance the split will enable it to maintain its NYSE American listing
Nuburu said its unaudited financial statements for the three and six months ended June 30, 2026 should no longer be relied upon because of a material error in valuing a convertible note receivable from Tekne S.p.A. The company will restate those results in an amendment to its Q2 2026 Form 10-Q, and the correction increases the value of its assets by $761,001.
Error involved using a Tekne equity value of €15.2 million ($17.4 million) instead of €25.4 million ($29.0 million) to value the note as of June 30, 2026.
Fair value of the Tekne convertible note receivable rises from €20,523,000 ($23,446,999) to €21,189,000 ($24,208,000), an increase of $761,001.
The change in fair value of convertible notes receivable for the three and six months ended June 30, 2026 increases by the same amount.
Audit Committee discussed the restatement with independent auditor WithumSmith+Brown, PC.
American Battery Technology reported fiscal 2026 results for the year ended June 30, 2026, with revenue up 407% to $21.7 million and a net loss of $73.4 million, compared with $46.8 million a year earlier. Loss per share was $0.58 in both years, and cash rose to $49.5 million with no outstanding debt, though the filing gives no forward guidance.
Revenue rose to $21.7 million from $4.3 million in fiscal 2025.
Net loss attributable to common stockholders was $73.4 million, versus $46.8 million; basic and diluted loss per share was $0.58 in both years.
Adjusted gross profit (non-GAAP) was $1.7 million, compared with an adjusted gross loss of $6.2 million in fiscal 2025.
Cash and cash equivalents were $49.5 million as of June 30, 2026, up from $7.5 million, and the company reported no outstanding debt.
Bone Biologics said on September 10, 2026 that it received a Nasdaq letter because its stock closed below $1 per share for 30 consecutive business days. The company has 180 days, until March 9, 2027, to regain compliance, and it plans to seek stockholder approval for a reverse stock split at its upcoming annual meeting. The notice has no immediate effect on the stock's listing, but a failure to regain compliance could lead to delisting proceedings.
Nasdaq letter dated September 10, 2026 cites closing bid price below $1 per share for the last 30 consecutive business days
Compliance period runs 180 calendar days, until March 9, 2027
Regaining compliance requires a closing bid price of at least $1 for 10 consecutive business days
Company intends to seek stockholder approval for a reverse stock split at its upcoming annual meeting
On September 11, 2026, ProFrac and the parties to its Alpine term loan signed Amendment No. 5, which cuts required quarterly principal payments to $0 through March 31, 2028 and extends maturity to February 15, 2030. The same day, $60 million of term loans was assigned to THRC Holdings and Farris C. Wilks, a co-founder and principal stockholder, and was repaid through the transfer of 2,306,806 Flotek shares owned by a ProFrac subsidiary, which gives the company near-term repayment relief but also a related-party transaction and tighter cash-flow and distribution terms.
Quarterly amortization reduced from $15 million to $0 for quarters ending September 30, 2026 through March 31, 2028, then $10 million per quarter.
Maturity extended from January 26, 2029 to February 15, 2030; PFP Holding may pay 675 basis points of interest in kind for 12 months from September 1, 2026.
$60 million of 2026 Term Loans assigned to THRC Holdings ($34.32 million) and Farris C. Wilks ($25.68 million) and cancelled in exchange for 2,306,806 Flotek shares.
Borrower must prepay 100% of excess cash flow each quarter, and company distributions are restricted to a $1 million annual basket.
AIG said Jon Hancock, Executive Vice President and Chief Executive Officer of General Insurance, will retire and become Senior Advisor effective December 31, 2026. As Senior Advisor he will report to AIG President and CEO Eric Andersen and advise on strategic priorities. The filing describes a planned leadership transition in one business unit rather than a change in financial results.
Jon Hancock, EVP and CEO of General Insurance, will retire and transition to Senior Advisor role
Transition effective December 31, 2026
Hancock will report to Eric Andersen, President & CEO of AIG
Filing cites more than six years in executive roles at AIG and a 40-year insurance career
Range Capital Acquisition Corp. received a Nasdaq notice on September 11, 2026, saying it does not meet the 400 Total Holders requirement for continued listing on the Nasdaq Global Market. Nasdaq says the notice is a deficiency notification, not an imminent delisting, and it has no current effect on the listing or trading of the company's securities.
Notice received September 11, 2026, under Nasdaq Listing Rule 5450(a)(2), which requires at least 400 Total Holders
The company has 45 calendar days to submit a plan to regain compliance
If Nasdaq accepts the plan, it may grant an extension of up to 180 calendar days from the notice date; if not, the company can appeal to a Nasdaq Hearings Panel
The company is considering actions to regain compliance, but there is no assurance it will do so
Sturm Ruger amended its rights agreement with Computershare, moving the final expiration date from October 13, 2026 to September 16, 2026, which terminates the plan at the close of business that day. The company said regulatory conditions under its Strategic Cooperation Agreement with Beretta Holding have been satisfied, and the board decided an active rights plan is no longer necessary.
Final expiration date accelerated from October 13, 2026 to September 16, 2026
Rights Plan terminates at close of business on September 16, 2026; shareholders need take no action
Amendment follows satisfied regulatory conditions under the Beretta Holding Strategic Cooperation Agreement, whose terms remain unchanged
Amendment No. 1 dated September 15, 2026 filed as Exhibit 4.1
Aeluma, Inc. reported fiscal 2026 results for the year ended June 30, 2026, with full-year revenue of $4.5 million, down from $4.7 million, and a net loss of $9.2 million, up from $3.0 million. The company said the losses reflected investments in new hires and manufacturing readiness, and it had $56.0 million in cash and cash equivalents at year-end, which it says will support its commercialization plans.
Q4 fiscal 2026 revenue was $0.6 million, versus $1.3 million in the same quarter of 2025; Q4 net loss was $4.0 million, or $0.22 per share, versus $0.9 million, or $0.05 per share.
Full-year net loss was $9.2 million, or $0.52 per share, compared with $3.0 million, or $0.23 per share, in fiscal 2025.
Adjusted EBITDA loss for the full year was $5.2 million, compared with a gain of $0.2 million a year earlier.
Cash and cash equivalents were $56.0 million at June 30, 2026; the company disclosed a letter of intent for up to $30 million in CHIPS R&D funding, which remains subject to definitive agreement negotiations.
Lennar reported third-quarter 2026 results for the period ended August 31, with net earnings of $284 million, or $1.19 per diluted share, down from $591 million, or $2.29, a year earlier. Revenue fell to $8.0 billion from $8.8 billion, and the company lowered its full-year 2026 delivery target to 80,000-81,000 homes, which weighs on shareholders' expectations for the year.
Q3 net earnings of $284 million, or $1.19 per diluted share, versus $591 million, or $2.29, in Q3 2025; excluding mark-to-market losses and one-time items, EPS was $1.23
Total revenues of $8.0 billion versus $8.8 billion; deliveries of 20,840 homes, down 3%; new orders of 20,879 homes, down 9%
Full-year 2026 delivery target cut to approximately 80,000-81,000 homes from 82,000-83,000 homes
Q4 2026 guidance: 22,000-23,000 deliveries, gross margin of 15.5%-16.0%, and new orders of 19,500-20,500 homes
Public Storage's subsidiary PS Canada Finance ULC completed a C$400 million offering of 4.540% senior notes maturing September 16, 2033, guaranteed by Public Storage and its subsidiary PSOC. The filing describes a standard debt issuance with covenants limiting mergers and requiring PSOC to keep unencumbered assets at or above 125% of unsecured debt.
Notes: C$400 million, 4.540% fixed interest, payable semi-annually from March 16, 2027
Maturity: September 16, 2033; redeemable at make-whole price, or at 100% of principal plus accrued interest from July 16, 2033
Covenant: PSOC must maintain unencumbered assets of at least 125% of total unsecured indebtedness
Kforce Inc. entered into a Rule 10b5-1 stock trading plan on September 15, 2026, to repurchase its common stock under the share repurchase program authorized by its Board of Directors. Repurchases can begin no earlier than September 16, 2026, and run through October 28, 2026, through an independent broker subject to price, market, volume and timing constraints.
Plan entered into on September 15, 2026, under Rule 10b5-1 of the Securities Exchange Act of 1934
Repurchases permitted from September 16, 2026, through October 28, 2026
Repurchases administered by an independent broker within constraints set in the Plan
The filing does not state the number of shares or dollar amount to be repurchased
On September 10, 2026, Empire Petroleum Corporation issued a $3,250,000 promissory note to Petroleum Independent & Exploration, LLC, which has fully advanced the funds for general working capital. The note matures March 10, 2028 and carries 6% annual interest, and PIE may convert principal into common stock at $2.838 per share from November 9, 2026, which would issue 1,145,173 shares if fully converted. The filing adds debt and could dilute existing shareholders if converted, and it contains no revenue, profit or guidance figures.
$3,250,000 note issued September 10, 2026 to PIE; full amount advanced as of that date
6% annual interest, rising to 9% on any principal unpaid after the March 10, 2028 maturity; accrued interest payable in cash at maturity
Convertible at PIE's option from November 9, 2026 to maturity at $2.838 per share, for up to 1,145,173 shares
Prepayable without penalty on at least five business days' written notice; company will seek NYSE American approval for the underlying shares
Fluence Energy lowered its fiscal 2026 guidance on September 16, 2026, citing delays in ramping up its Houston contract manufacturing facility and continuing supply chain issues affecting U.S. production. Revenue is now expected at about $2.4 billion, down from a prior guidance midpoint of about $3.0 billion, and the adjusted EBITDA loss is now expected at about $200.0 million, versus a prior midpoint loss of about $10.0 million. The company also named Bernerd Da Santos as executive vice president and chief operating officer, and management plans to provide a fiscal 2027 business plan when it reports fiscal 2026 results.
Fiscal 2026 revenue guidance now approximately $2.4 billion, versus a prior midpoint of approximately $3.0 billion.
Fiscal 2026 adjusted EBITDA loss now approximately $200.0 million, versus a prior midpoint loss of approximately $10.0 million.
The company cites delays in the ramp-up of its Houston contract manufacturing facility; the contract manufacturer has implemented corrective actions that have increased daily production.
Bernerd Da Santos, formerly of AES, took the chief operating officer role effective September 15, 2026; Peter Williams, senior vice president and chief product officer, was terminated on September 11, 2026.
On September 16, 2026, Teva's subsidiaries issued €1.5 billion and $3.2 billion of senior unsecured notes due 2032 to 2037, guaranteed by Teva Pharmaceutical Industries. Teva plans to use the proceeds to fund conditional redemptions of several existing notes, pay related fees, and for general corporate purposes. The filing shows a refinancing of existing debt rather than a stated change in operations or results.
Euro notes: €1.0 billion of 4.250% notes due March 16, 2033, and €500 million of 4.625% notes due September 16, 2036
USD notes: $1.2 billion of 5.250% notes due January 16, 2032; $1.0 billion of 5.500% notes due January 16, 2034; and $1.0 billion of 5.750% notes due January 16, 2037
Conditional redemptions include up to $450 million of 4.750% notes due 2027 and up to €1.15 billion of 4.375% notes due 2030, reduced from up to €1.25 billion
Teva may redeem notes, or issue further redemption notices, at its sole discretion and is under no obligation to do so
Generac agreed to issue Amazon a warrant to buy up to 1,693,745 common shares at $200.9266 per share, alongside a long-term backup generator supply agreement. The warrant vests in tranches tied to gross payments from Amazon and its affiliates, up to $8 billion in total, and can be exercised through September 16, 2033.
Warrant covers up to 1,693,745 shares at $200.9266 per share; 307,954 shares vested immediately.
Vesting tied to aggregate gross payments, net of certain offsets, from Amazon for backup generators for Amazon data centers, up to $8 billion.
Initial backup generator deliveries are expected to total $2.4 billion in 2027 and 2028.
Warrant is exercisable on or before September 16, 2033; shares issued without SEC registration under Section 4(a)(2).
NIKE's board increased its size to twelve directors and appointed Alexandre Arnault, Deputy CEO of Moët Hennessy at LVMH, as a director effective immediately on September 15, 2026. The filing says his committee assignments have not yet been determined, and he received a $200,000 sign-on award of restricted Class B shares that is forfeitable if he leaves the board before the first anniversary of the grant.
Board expanded to twelve directors; Arnault's initial term runs to the 2027 annual meeting of shareholders
Arnault, 34, has been Deputy CEO of Moët Hennessy since February 2025 and has served on the LVMH board since April 2024
Sign-on award of restricted Class B Common Stock valued at $200,000, granted September 15, 2026
Committee assignments for Arnault have not yet been determined
AES disclosed that Bernerd Da Santos, who had moved from President of US & Renewables to Chairman of the AES Clean Energy Board in April 2026, left the company effective September 14, 2026, to become Executive Vice President and Chief Operating Officer at Fluence Energy, Inc. His separation agreement provides severance under the company's executive severance plan, which matters to shareholders because it is a cost tied to a senior leadership departure.
Departure effective September 14, 2026; he accepted a role as EVP and COO at Fluence Energy, Inc.
Severance equal to one times annualized base salary plus annual target bonus for fiscal 2026, plus a pro-rata fiscal 2026 bonus at target performance
He will also receive applicable retirement benefits under company plans; the filing gives no dollar amounts
Full separation agreement to be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2026
Vivani Medical disclosed in a Regulation FD filing that it expects pricing and closing of the previously announced merger of its subsidiary Cortigent into a ClearOne subsidiary to occur in October 2026. The filing reiterates the transaction structure but gives no financial terms, and it carries a risk that the deal may not be completed.
Cortigent, a wholly owned Vivani subsidiary, will merge with and into CLRO Merger Sub, Inc., becoming a wholly owned subsidiary of ClearOne, Inc.
Vivani anticipates pricing and closing of the Transaction in October 2026.
Forward-looking statements cite the Company's inability to consummate the Transaction as a key risk.
BrightSpire Capital's subsidiaries completed the sale of the Net Lease 1 Investment, two industrial properties in Tolleson, Arizona and Tracy, California, on September 14, 2026, under a purchase agreement dated June 12, 2026. The total consideration was $300.0 million, including $97.9 million in cash net of closing costs, with the rest covered by the buyers assuming existing loans. The filing's pro forma figures show an approximate $60.4 million gain on sale, but these are illustrative and not actual reported results.
Total consideration of $300.0 million: $97.9 million in cash net of closing and other transaction expenses, plus assumed loans.
Buyers assumed a mortgage loan with an original principal amount of $94.0 million and a mezzanine loan with an original principal amount of $106.0 million.
Pro forma statements show an approximate $60.4 million gain on sale and a pro forma net income of $27.7 million for 2025, compared with a historical net loss of $31.1 million attributable to common stockholders.
Pro forma figures assume the sale occurred January 1, 2025, and the filing states they should not indicate future results.
EagleRock Land's board approved 2026 long-term incentive awards on September 10, 2026, including performance share units for CEO Greg Pipkin Jr. and CFO Neal H. Shah. The filing describes vesting tied to total shareholder return over a performance period ending May 14, 2029, and the awards are subject to the company's clawback policies.
CEO Greg Pipkin Jr. received 270,147 PSUs at target, all in performance share units.
CFO Neal H. Shah received 71,429 PSUs at target and 47,619 RSUs, a 60%/40% split.
PSUs are earned based on relative and absolute TSR over a performance period from May 14, 2026 to May 14, 2029, capped at 250% of target.
RSUs vest in three equal annual installments; the board approved the awards on September 10, 2026.
AECOM said Chief Legal Officer David Gan will retire, with his role passing to Manav Kumar, the company's General Counsel, Corporate and Global Head of Public Affairs, effective October 2, 2026. Gan will then serve as Senior Advisor until his retirement in the second half of 2027. The filing describes a planned leadership transition with no financial results or guidance included.
David Gan provided notice of retirement on September 14, 2026, and remains in his role through October 2, 2026.
Manav Kumar, age 42, becomes Chief Legal Officer effective October 2, 2026, and has been General Counsel, Corporate and Global Head of Public Affairs since December 2024.
Gan keeps his existing base salary as Senior Advisor until his retirement in the second half of 2027.
Gan remains eligible for a fiscal year 2026 annual incentive bonus but will not participate in annual or long-term incentive programs in fiscal year 2027.
Gossamer Bio appointed Gregory A. Ciongoli as a Class III director effective September 16, 2026, with a term expiring at the 2027 annual meeting, and also named him to the Audit Committee. The Board determined he is independent under Nasdaq listing rules, and he is a purchaser in the 2026 private placement, so his board seat ties him to securities he has agreed to buy in the company.
Appointed Class III director effective September 16, 2026; initial term expires at the 2027 annual meeting of stockholders
Receives a $40,000 annual cash retainer for Board service and a $7,500 annual cash retainer for Audit Committee service
Purchased initial closing pre-funded warrants in the 2026 PIPE (initial closing August 24, 2026) and agreed to buy second closing and FDA approval warrants
Board determined he is independent under Nasdaq Global Select Market listing requirements
Oaktree Specialty Lending Corporation issued $300.0 million of 7.000% unsecured notes maturing September 16, 2031, and the transaction closed the same day. The company expects to use the net proceeds to reduce borrowings under its senior secured revolving credit facility and for general corporate purposes, which may include repaying 2.700% notes due 2027 at maturity.
Notes: $300.0 million aggregate principal, 7.000% annual interest, paid semiannually on March 16 and September 16 starting March 16, 2027
Maturity September 16, 2031; callable at a make-whole price (Treasury Rate plus 40 basis points) before August 16, 2031, and at par thereafter
Holders may require repurchase at 100% of principal plus accrued interest upon a Change of Control Repurchase Event
Offering made under shelf registration No. 333-292920; transaction closed September 16, 2026
Mission Produce said it will close three facilities in its distribution network, consolidating its Swedesboro, New Jersey and Dallas-area operations and closing the former Calavo facility in Jacksonville, Florida, as part of its integration of Calavo Growers, which the company completed on May 28, 2026. The company has not yet estimated total costs, but it has disclosed several specific charges, and it plans to report the full amounts in future SEC filings.
Facility actions were determined on September 11, 2026: consolidate Swedesboro, New Jersey into one facility; combine Dallas-area facilities into one in Garland, Texas; close the Calavo facility in Jacksonville, Florida.
Expected employee severance and related benefits of approximately $1.4 million, which are expected to be cash charges.
Expected accelerated depreciation of approximately $8.6 million and estimated asset retirement obligations of approximately $5.4 million; lease termination costs are not yet determinable.
The company cannot yet make a good faith estimate of the total costs or future cash charges.
AH Realty Trust filed its Q2 2026 investor presentation, which CEO Shawn Tibbetts and CFO Matthew Barnes-Smith will use in investor meetings starting September 16, 2026. The deck gives a revised 2026 outlook with higher same-store NOI growth ranges and reports leverage down to 7.1x after the $485 million multifamily portfolio sale. For shareholders, the filing shows lower debt and a larger buyback authorization, though it does not compare the quarter with prior-year results.
Revised 2026 FFO, As Adjusted per diluted share outlook of $0.53 to $0.57, or $52.3 million to $56.3 million in total FFO, As Adjusted.
Raised 2026 same-store cash NOI growth ranges: retail 2.50% to 3.50% and office 2.75% to 3.75%.
Net debt to total adjusted EBITDAre fell to 7.1x in 2Q26 from about 8.3x in 1Q26; target range is 5.5x to 6.5x.
Share repurchase authorization increased to $100 million; about 5.6 million shares repurchased for $33.2 million through June 30, 2026.
Great Southern Bancorp, the holding company for Great Southern Bank, declared a $0.43 per common share dividend for the third quarter of 2026. The filing describes it as the 147th consecutive quarterly dividend paid to common stockholders, and it does not report any change in the amount from prior periods or any financial results.
Dividend: $0.43 per common share for the third quarter of 2026
Record date: September 28, 2026; payable October 14, 2026
Filing describes this as the 147th consecutive quarterly common dividend
Texas Capital Bancshares and Chief Risk Officer David Oman mutually agreed that he will leave the role effective September 16, 2026. The company said the departure is not tied to any disputes, financial condition, internal controls, or enterprise risk management matters.
David Oman departs as Chief Risk Officer effective September 16, 2026
David Youngberg, Chief Credit Officer, takes on Chief Risk Officer duties in addition to his current role
The company has started an internal and external search for a successor, and Youngberg is a candidate
Expand Energy Corporation completed its previously announced acquisition of Twin Eagle Holdings N.A., LLC on September 16, 2026. At the closing, Executive Vice President Dan Turco stopped serving as Executive Vice President—Marketing and Commercial and now serves as Executive Vice President of Commercial Activities, focusing on LNG and assisting with gas marketing integration.
Acquisition of Twin Eagle Holdings N.A., LLC closed on September 16, 2026
Dan Turco's title changed to Executive Vice President of Commercial Activities, effective at closing
Turco will focus on LNG and help with gas marketing integration
The filing does not state the purchase price or deal terms
CalciMedica received a Nasdaq letter on September 15, 2026 confirming it has regained compliance with the minimum bid price rule, after its closing bid stayed at $1.00 or greater for 10 consecutive business days from August 31 to September 14, 2026. The company has no outstanding Nasdaq deficiency notices, which removes the risk of delisting over the bid price issue for shareholders.
Nasdaq notice of non-compliance dated March 16, 2026, after the bid price was below $1.00 for 30 consecutive business days
Compliance deadline was September 14, 2026, 180 calendar days after the notice
Nasdaq letter received September 15, 2026 confirmed compliance with Listing Rule 5550(a)(2)
Company reports no outstanding Nasdaq deficiency notices as of the filing date
Exicure received a Nasdaq extension on September 10, 2026, to regain compliance with the $2.5 million minimum stockholders' equity requirement, with a deadline of December 2, 2026. The company said the extension does not mean it has regained compliance, and failure to meet the deadline could lead Nasdaq to issue a delisting determination that the company could appeal.
Nasdaq notified Exicure on June 5, 2026 that it did not meet the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
Nasdaq granted an extension on September 10, 2026, through December 2, 2026, for the company to regain compliance.
The company must publicly demonstrate compliance on or before December 2, 2026; Nasdaq will monitor compliance through the next periodic report.
If the terms are not met, Nasdaq may issue a written delisting determination, which Exicure could appeal to a Nasdaq Hearings Panel.
On September 15, 2026, My Size agreed to sell up to 1,308,901 shares of common stock, or pre-funded warrants in their place, at $1.91 each, along with Series C and Series D warrants, in a private placement expected to bring in about $2.5 million in gross proceeds before fees. The warrants are exercisable at $1.66 per share, so the deal would add up to roughly 2.6 million potential shares to the share count, which dilutes existing shareholders, and the company says the proceeds will go to general corporate purposes, including working capital.
Up to 1,308,901 shares or pre-funded warrants at $1.91 each; gross proceeds of about $2.5 million before placement agent fees and expenses
Series C and Series D warrants, each for up to 1,308,901 shares, exercisable immediately at $1.66 per share; Series C term is five years and Series D term is 18 months from the resale registration effective date
H.C. Wainwright & Co. is exclusive placement agent, with a 7% cash placement fee, a 1.0% management fee and placement agent warrants for 91,623 shares at $2.3875
Offering expected to close on or about September 16, 2026; company must file a resale registration statement within 15 days of signing and is barred from variable rate transactions for one year after the effective date
On September 11, 2026, USBC drew an additional $3.0 million under its Master Loan Agreement with Payward Interactive, bringing total principal outstanding to $21.0 million at a fixed 8.5% annual rate, maturing September 11, 2027. The loan is secured solely by 479 Bitcoin held by an affiliate custodian, and the filing says a roughly 27.4% drop in that collateral's value would have pushed the collateral coverage ratio to the 130% collateral call margin as of September 14, 2026, though no collateral calls, mandatory repayments or liquidations had occurred.
Fifth draw of $3.0 million on September 11, 2026; total outstanding rises to $21.0 million under the $25.0 million facility
Fixed interest rate of 8.5% per annum, with maturity on September 11, 2027 unless terminated earlier
479 Bitcoin collateral; a roughly 27.4% decline would have reached the 130% collateral call margin as of September 14, 2026
No collateral calls, mandatory repayments or liquidation events had occurred as of September 14, 2026
Littelfuse said Deepak Nayar, Senior Vice President and General Manager of the Electronics business, will become Special Advisor to the CEO effective January 1, 2027, and Dr. Karim Hamed will take an expanded role leading the combined Electronics and Semiconductor businesses. Under a special advisor agreement, Mr. Nayar will receive monthly payments totaling $1,004,220 for the advisory term, and the company said he will retire at the end of 2027.
Nayar's Electronics role ends December 31, 2026; he becomes Special Advisor to the CEO effective January 1, 2027.
Dr. Karim Hamed, who joined Littelfuse in 2025 as SVP and General Manager of the Semiconductor business, takes the expanded SVP and General Manager role for the CCDI Market & Electronics Segment effective January 1, 2027.
Nayar's advisory payments total $1,004,220, made up of a $557,900 base salary and $446,320 in target annual incentive award.
During the advisory term, Nayar will not receive new annual incentive or long-term incentive awards, but his remaining long-term awards may vest upon his retirement.
ACP Holdings Acquisition Corp., a Cayman Islands special purpose acquisition company, signed a business combination agreement on September 15, 2026, under which May Mobility, Inc. would merge into a subsidiary of ACP and become a publicly listed company named May Mobility, Inc. on Nasdaq under the ticker MAY. ACP shareholders must approve the deal, and the 8-K sets an outside closing date of May 26, 2027, while the press release says closing is expected by year-end; the amount of gross proceeds depends on how many public shareholders redeem their shares.
Aggregate consideration to May Mobility holders is based on a $1.35 billion purchase price at $10.00 per share, with a pro forma enterprise value of approximately $1.4 billion.
Gross proceeds of up to $337 million, including up to $217 million from the ACP trust account (subject to redemptions) and a fully committed $120 million PIPE.
Closing is expected on or before May 26, 2027, subject to ACP and May Mobility shareholder approvals and other customary conditions.
May Mobility generated approximately $10 million in revenue and burned approximately $93 million in cash in 2025, according to the press release.
Schneider National Leasing, a wholly-owned subsidiary, entered a $350 million credit agreement on September 10, 2026, and terminated its existing $250 million credit agreement from November 2022, which had no outstanding borrowings. The company also amended its unsecured term loan agreement to conform its covenants to the new facility.
New $350 million credit facility matures September 10, 2031, with a Nov. 22, 2029 maturity if the term loan is not extended or refinanced in time
Borrower can request a commitment increase of up to $350 million, for a total potential commitment of $700 million
Existing $250 million credit agreement terminated effective September 10, 2026, with no outstanding borrowings
Term loan agreement, maturing November 22, 2029, amended to align covenants with the new facility
Jones Lang LaSalle appointed Paul Morgan as its new Chief Operating Officer, effective immediately, reporting to CEO and President Christian Ulbrich. The company is centralizing its enterprise-wide operational expertise into one global operations function under the new role, as part of its Accelerate 2030 long-term strategy. The filing contains no financial results or guidance, so the effect on shareholders is not quantified.
Paul Morgan, age 54, appointed Chief Operating Officer effective September 16, 2026, a newly created role
Morgan reports to CEO and President Christian Ulbrich and joins the Global Executive Board
Morgan previously was Global Chief Operating Officer of Real Estate Management Services and CEO of Workplace Management; he joined JLL in 2016 after 18 years at Johnson Controls
Mercury Systems said its independent directors approved Amendment No. 2 extending Chairman and CEO William L. Ballhaus's employment agreement to August 15, 2030, with the rest of the agreement unchanged. The company also reaffirmed the financial guidance it gave on its August 18, 2026 earnings call. The filing contains no new financial results or revised guidance, so the update mainly signals leadership continuity for shareholders.
Board approved Amendment No. 2 on September 15, 2026, extending the initial term to August 15, 2030
Ballhaus has served as Chairman and CEO for three years, according to the press release
Company reaffirmed financial guidance first provided on its August 18, 2026 earnings call
Press release issued September 16, 2026 and furnished, not filed, under Item 7.01
Xenetic Biosciences agreed on September 14, 2026 to acquire all share capital of Swiss company Santersus AG in exchange for newly issued Xenetic common stock, subject to Xenetic stockholder approval and other conditions. On a pro forma basis, existing Xenetic equity holders would own about 15.0% of the combined company and Santersus equity holders about 85.0%, subject to adjustment based on Xenetic's net cash at closing, so current shareholders' stake would be substantially diluted.
Santersus equity holders expected to own about 85.0% and Xenetic equity holders about 15.0% of the combined company on a fully diluted basis.
Closing is expected in the fourth quarter of 2026, subject to stockholder approval, Nasdaq listing approval and an effective Form S-1 resale registration statement.
Xenetic may owe Santersus a $500,000 termination fee under specified circumstances; either party may reimburse the other for fees and expenses up to $300,000.
The combined company would be renamed Santersus Bio, Inc. with an eight-member board, six designated by Santersus, and expected to trade under the symbol SNTS.
CLEAR Secure's President Michael Barkin, who is also a board member, will move to an advisory role on October 15, 2026, and resign from the board effective the same day, under a transition agreement dated September 15, 2026. Separately, EVP of Aviation Kyle McLaughlin will leave on October 2, 2026, and the company has started a search for his successor. Both departures are described as not involving any disagreement with the company, and the filing reports no financial results or guidance changes.
Michael Barkin moves to an advisory role on October 15, 2026, and resigns from the Board effective that date
Barkin's advisory service runs through December 31, 2026, at $300,000 per full month
Kyle McLaughlin, EVP Aviation, resigns to pursue a new opportunity; last day October 2, 2026
The company has initiated a search for McLaughlin's successor
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.